Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Lower or Higher Oxygenation Targets for Acute Hypoxemic Respiratory Failure

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Monoclonal Antibody for Patients with Covid-19. Reply

    Research output: Contribution to journalLetterpeer-review

  3. A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Five-Year Outcomes of PFO Closure or Antiplatelet Therapy for Cryptogenic Stroke

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Assessment of assumptions of statistical analysis methods in randomised clinical trials: the what and how

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Considerations on the strengths and limitations of using disease-related mortality as an outcome in clinical research

    Research output: Contribution to journalComment/debateResearchpeer-review

  3. Training non-intensivist doctors to work with COVID-19 patients in intensive care units

    Research output: Contribution to journalJournal articleResearchpeer-review

  • HOT-ICU Investigators
  • Diana Bertelsen Jensen (Member of study group)
  • Kasper Mørk Sørensen (Member of study group)
  • Patrick Sprogøe Rasmussen (Member of study group)
  • Andreas Rovsing Hjortdal (Member of study group)
  • Nanna Reiter (Member of study group)
  • Niels Erikstrup Clausen (Member of study group)
  • Lars Hein (Member of study group)
  • Michael Ibsen (Member of study group)
  • Sigurður Þór Sigurðsson (Member of study group)
View graph of relations

BACKGROUND: Patients with acute hypoxemic respiratory failure in the intensive care unit (ICU) are treated with supplemental oxygen, but the benefits and harms of different oxygenation targets are unclear. We hypothesized that using a lower target for partial pressure of arterial oxygen (Pao2) would result in lower mortality than using a higher target.

METHODS: In this multicenter trial, we randomly assigned 2928 adult patients who had recently been admitted to the ICU (≤12 hours before randomization) and who were receiving at least 10 liters of oxygen per minute in an open system or had a fraction of inspired oxygen of at least 0.50 in a closed system to receive oxygen therapy targeting a Pao2 of either 60 mm Hg (lower-oxygenation group) or 90 mm Hg (higher-oxygenation group) for a maximum of 90 days. The primary outcome was death within 90 days.

RESULTS: At 90 days, 618 of 1441 patients (42.9%) in the lower-oxygenation group and 613 of 1447 patients (42.4%) in the higher-oxygenation group had died (adjusted risk ratio, 1.02; 95% confidence interval, 0.94 to 1.11; P = 0.64). At 90 days, there was no significant between-group difference in the percentage of days that patients were alive without life support or in the percentage of days they were alive after hospital discharge. The percentages of patients who had new episodes of shock, myocardial ischemia, ischemic stroke, or intestinal ischemia were similar in the two groups (P = 0.24).

CONCLUSIONS: Among adult patients with acute hypoxemic respiratory failure in the ICU, a lower oxygenation target did not result in lower mortality than a higher target at 90 days. (Funded by the Innovation Fund Denmark and others; HOT-ICU ClinicalTrials.gov number, NCT03174002.).

Original languageEnglish
JournalThe New England journal of medicine
Volume384
Issue number14
Pages (from-to)1301-1311
Number of pages11
ISSN0028-4793
DOIs
Publication statusPublished - 8 Apr 2021

ID: 61828500